Celvivo

📍 Odense, Denmark🗓 Founded 2014👥 30 employees💰 Last funded Apr 2025
Biotechnology Research🌐 celvivo.com
Website LinkedIn
At Celvivo, we’re on a mission to help scientists push the frontiers of 3D cell culture. Our Clinostat-based technology enables cells in vitro to recover lost physiological attributes, re‑establish intercellular communication, and perform more like they do in vivo - Whether you work with spheroids or organoids. We designed the Celvivo Clinostar and ClinoReactor on four core principles: 3D cell culture should be relevant, abundant, easy‑to‑use, and reproducible. In close collaboration with researchers worldwide, we’re solving long‑standing challenges like active diffusion bias and shear stress, so your models can be more predictive and more meaningful. Friendly, nerdy, premium, and pioneering - that’s who we are. And with the most user‑friendly system for organoids yet, we invite you to join us in shaping the future of 3D cell culture based research. Celvivo Refine your research
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Celvivo?
Celvivo has 1 investors on record on gritt.io.
When did Celvivo last raise funding?
The most recent investment in Celvivo recorded on gritt.io was in April 2025.
When was Celvivo founded?
Celvivo was founded in 2014.
What industry is Celvivo in?
Celvivo operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Celvivo based?
Celvivo is headquartered in Odense, Denmark.